Markets:

Overview

News

Currencies

International

Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

8.520 +8.519 (+1064900.00%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs ↗

December 20, 2023

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n

Via Benzinga

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

December 13, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference

December 06, 2023

From Vir Biotechnology, Inc.

Via Business Wire

What 8 Analyst Ratings Have To Say About Vir Biotechnology ↗

September 08, 2023

Via Benzinga

Is Vir Biotechnology Stock a Buy? ↗

August 11, 2023

The biotech is out to prove that it isn't just a "pandemic stock."

Via The Motley Fool

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally ↗

November 30, 2023

explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

Via InvestorPlace

From laggards to leaders: Small caps on the rise

November 27, 2023

Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.

Via MarketBeat

Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023

November 13, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023

November 10, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

November 08, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 02, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer

October 30, 2023

From Vir Biotechnology, Inc.

Via Business Wire

Earnings Scheduled For November 2, 2023 ↗

November 02, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

Via Benzinga

3 Bill Gates Stocks to Buy for Billionaire-Like Returns ↗

October 27, 2023

Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.

Via InvestorPlace

7 Biotech Stocks to Get In Now Before Investors Catch On ↗

October 23, 2023

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

Via InvestorPlace

Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference

October 12, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023

October 11, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023

October 05, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats

October 03, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs ↗

September 27, 2023

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV

September 20, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades ↗

September 08, 2023

BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14,

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 ↗

September 08, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 08, 2023

Friday's session saw 225 companies set new 52-week lows.

Via Benzinga

Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

September 08, 2023

U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 05, 2023

On Tuesday morning, 164 companies achieved new lows for the year.

Via Benzinga

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences

August 29, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results

August 03, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.